Next-Gen Test Tube Baby Born

A baby has been born using in vitro fertilization aided by next-generation sequencing of embryos for genetic abnormalities.

By | July 10, 2013

 

WIKIMEDIA, ERNEST FAbnormalities in the DNA of embryos account for the two-thirds failure rate of in vitro fertilization (IVF)—a procedure where eggs are fertilized by sperm in a dish, then later implanted in the uterus. Genetic tests exist to screen for embryos with chromosomal or genetic defects prior to implantation, but the tests are expensive and have drawbacks. Researchers at the University of Oxford have developed a relatively inexpensive next-generation sequencing technique that overcomes the limitations of previous tests, and has already been used in the IVF procedure that resulted in the birth of a baby boy in May. The research was reported Monday (July 8) at the annual meeting of the European Society of Human Reproduction and Embryology in London.

The new sequencing technique allows researchers to examine each embryo created with IVF for abnormal numbers of chromosomes, individual gene mutations, and mitochondrial genome mutations. The analysis can be completed in only 16 hours, meaning embryos do not need to be frozen awaiting test outcomes. The researchers claim the new test will be cheaper than current screening procedures, which can cost thousands of dollars.

“Next-generation sequencing improves our ability to detect these abnormalities and helps us identify the embryos with the best chances of producing a viable pregnancy,” said Dagan Wells, a molecular geneticist at the NIHR Biomedical Research Centre at the University of Oxford, in a statement. “Potentially, this should lead to improved IVF success rates and a lower risk of miscarriage.”

The new screen helped Marybeth Scheidts, 36, and her husband David Levy, 41, of Philadelphia, achieve a successful pregnancy, resulting in the birth of their son, Connor Levy, in May. The couple had tried to conceive naturally for 4 years and had also tried artificial insemination.

“Anything that is so significantly going to impact pregnancy rates is going to become standard,” Michael Glassner, the fertility doctor at the Main Line Fertility Clinic where the screening procedure took place, told BBC News. He added that he thinks the test will become standard within 5 years.

“Our next step is a randomized clinical trial to reveal the true efficacy of this approach—and this will begin later this year,” said Wells in the statement.

(Hat tip to GenomeWeb)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: PastToTheFuture

PastToTheFuture

Posts: 76

July 11, 2013

This article is about one of the most important topics of this century. The only topic more important will be about "de novo" mutations, why this topic here is so important.

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech